WhiteOak Capital Pharma and Healthcare Fund
Direct · Growth ₹17.82
25 Sep 2026
NAV
—
Sharpe
-15.4%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
0.67%
TER
Not enough data to compute SIP returns.
Not enough data to compute rolling returns.
-15.4%
Max Drawdown
2 mo
Drawdown Duration
5 mo
Recovery Time
-2.8%
Avg Drawdown
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +20.88 | 0.59 | 72.7% | 44.3% | 21.9% | -2.9% |
| 3 Years | +15.85 | 0.63 | 77.5% | 50.8% | 20.5% | 3.6% |
| 5 Years | +8.08 | 0.63 | 77.5% | 50.8% | 11.9% | 2.1% |
| 7 Years | +4.95 | 0.63 | 77.5% | 50.8% | 8.3% | 1.5% |
| 10 Years | +2.66 | 0.63 | 77.5% | 50.8% | 5.8% | 1.1% |
| 12 Years | +1.79 | 0.63 | 77.5% | 50.8% | 4.8% | 0.9% |
| 15 Years | +0.93 | 0.63 | 77.5% | 50.8% | 3.8% | 0.7% |